Grigorescu Raluca Roxana, Husar-Sburlan Ioana Alexandra, Rosulescu Georgiana, Bobirca Anca, Cerban Razvan, Bobirca Florin, Florescu Madalina Marieta
Gastroenterology Department, "Sfanta Maria" Hospital, 011172 Bucharest, Romania.
Department of Internal Medicine and Rheumatology, Dr. I. Cantacuzino Clinical Hospital, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Life (Basel). 2023 Feb 9;13(2):475. doi: 10.3390/life13020475.
In recent years, we have faced an increasing incidence of inflammatory bowel disease (IBD), especially among young people, affecting them during their reproductive years. The paucity of data and reduced knowledge regarding the evolution of the disease during pregnancy and the adverse effects of the therapy on the mother and infant increase voluntary childlessness in this group of patients. Depending on the type of IBD, severity and surgical or medical management, this can negatively affect the pregnancy. C-sections and the risk of low-birth-weight babies are higher in women with IBD, independent of active/inactive disease, while preterm birth, stillbirth and miscarriage are associated with disease activity. In the last period, medicinal therapy has evolved, and new molecules have been developed for better control of the lesions, but the effect on pregnancy and breastfeeding is still controversial. We conducted this review by studying the literature and recent research in order to have a better image of the practical management of IBD during pregnancy.
近年来,我们面临着炎症性肠病(IBD)发病率不断上升的情况,尤其是在年轻人中,且在他们的生育年龄段发病。关于该疾病在孕期的演变以及治疗对母婴的不良影响的数据匮乏且相关知识有限,这使得这组患者中自愿不育的情况增加。根据IBD的类型、严重程度以及手术或药物治疗情况,这可能会对妊娠产生负面影响。患有IBD的女性剖宫产和低体重儿风险更高,与疾病是否处于活动期无关,而早产、死产和流产则与疾病活动有关。最近,药物治疗有所发展,已开发出新型分子以更好地控制病变,但对妊娠和母乳喂养的影响仍存在争议。我们通过研究文献和近期研究进行了本综述,以便更好地了解孕期IBD的实际管理情况。